GlaxoSmithKline Manufacturing S.P.A. FDA Record
GlaxoSmithKline Manufacturing S.P.A. has 0 FDA recalls, 7 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "GlaxoSmithKline Manufacturing S.P.A." is on file.
- Latest recall
- D-0544-2024 · May 17, 2024 · filed under Glaxosmithkline
- Latest inspection
- Oct 26, 2023 · VAI
Newer recall under related name Glaxosmithkline: May 17, 2024, D-0544-2024.
Reviewing GlaxoSmithKline Manufacturing S.P.A. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check GlaxoSmithKline Manufacturing S.P.A. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 7 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Oct 26, 2023 | Torrile, Italy | Drugs | Voluntary Action Indicated (VAI) | 3002807114 |
| Sep 29, 2017 | Torrile, Italy | Drugs | Voluntary Action Indicated (VAI) | 3002807114 |
| Jul 22, 2016 | Torrile, Italy | Drugs | No Action Indicated (NAI) | 3002807114 |
| May 27, 2015 | Torrile, Italy | Drugs | Voluntary Action Indicated (VAI) | 3002807114 |
| Jul 10, 2013 | Torrile, Italy | Drugs | No Action Indicated (NAI) | 3002807114 |
| Sep 21, 2012 | Torrile, Italy | Drugs | No Action Indicated (NAI) | 3002807114 |
| Jun 28, 2011 | Torrile, Italy | Drugs | No Action Indicated (NAI) | 3002807114 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3002807114 | Torrile, Italy | 7 | Oct 26, 2023 |
GlaxoSmithKline Manufacturing S.P.A. and the FDA: common questions
Has GlaxoSmithKline Manufacturing S.P.A. received an FDA warning letter?
No FDA warning letter addressed to the name "GlaxoSmithKline Manufacturing S.P.A." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has GlaxoSmithKline Manufacturing S.P.A. received an FDA Form 483?
FDA has not published a Form 483 for "GlaxoSmithKline Manufacturing S.P.A." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect GlaxoSmithKline Manufacturing S.P.A.?
The most recent FDA inspection on file ended Oct 26, 2023 at Torrile, Italy and was classified VAI. FDA has 7 inspections of GlaxoSmithKline Manufacturing S.P.A. on file.
Need more than this page shows? Ask about GlaxoSmithKline Manufacturing S.P.A. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.